Impact of the COVID ‐19 pandemic on the in‐hospital diagnostic pathway of breast and colorectal cancer in the Netherlands: A population‐based study
Cancer Medicine · 2024
DOI: 10.1002/cam4.6861 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Medicine, 2024. Verfasst von Wouter Wolfkamp und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Research and Development, Netherlands Comprehensive Cancer Organisation (IKNL), Utrecht, the Netherlands. Hauptthemen laut MEDLINE: COVID-19, Colorectal Neoplasms, Breast Neoplasms. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 17 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: ZonMw.
Abstract (Originalsprache)
Background
In the Netherlands, the COVID‐19 pandemic resulted in a temporary halt of population screening for cancer and limited hospital capacity for non‐COVID care. We aimed to investigate the impact of the pandemic on the in‐hospital diagnostic pathway of breast cancer (BC) and colorectal cancer (CRC).
Methods
71,159 BC and 48,900 CRC patients were selected from the Netherlands Cancer Registry. Patients, diagnosed between January 2020 and July 2021, were divided into six periods and compared to the average of patients diagnosed in the same periods in 2017–2019. Diagnostic procedures performed were analysed using logistic regression. Lead time of the diagnostic pathway was analysed using Cox regression. Analyses were stratified for cancer type and corrected for age, sex (only CRC), stage and region.
Results
For BC, less mammograms were performed during the first recovery period in 2020. More PET‐CTs were performed during the first peak, first recovery and third peak period. For CRC, less ultrasounds and more CT scans and MRIs were performed during the first peak. Lead time decreased the most during the first peak by 2 days (BC) and 8 days (CRC). Significantly fewer patients, mainly in lower stages, were diagnosed with BC (−47%) and CRC (−36%) during the first peak.
Conclusion
Significant impact of the COVID‐19 pandemic was found on the diagnostic pathway, mainly during the first peak. In 2021, care returned to the same standards as before the pandemic. Long‐term effects on patient outcomes are not known yet and will be the subject of future research.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Research and Development, Netherlands Comprehensive Cancer Organisation (IKNL), Utrecht, the Netherlands.
- Department of Health Technology and Services Research, University of Twente, Enschede, the Netherlands.
- Department of Surgical Oncology, Catharina Cancer Institute, Eindhoven, the Netherlands.
- Department of Radiology, Leiden University Medical Center (LUMC), Leiden, the Netherlands.
- Biomedical Photonic Imaging Group, University of Twente, Enschede, the Netherlands.
- Department of Radiation Science & Technology, Delft University of Technology, Delft, the Netherlands.
ORCID-Profile: Sabine Siesling
Förderung
- ZonMw
Zitieren
APA
Wolfkamp, W., Meijer, J., van Hoeve, J. C., van Erning, F., de Geus-Oei, L. F., de Hingh, I., Veltman, J., Siesling, S., & COVID and Cancer‐NL Consortium (2024). Impact of the COVID ‐19 pandemic on the in‐hospital diagnostic pathway of breast and colorectal cancer in the Netherlands: A population‐based study. Cancer Medicine. https://doi.org/10.1002/cam4.6861
Vancouver
Wolfkamp W, Meijer J, van Hoeve JC, van Erning F, de Geus-Oei LF, de Hingh I, et al. Impact of the COVID ‐19 pandemic on the in‐hospital diagnostic pathway of breast and colorectal cancer in the Netherlands: A population‐based study. Cancer Medicine. 2024. doi:10.1002/cam4.6861
BibTeX
@article{Wolfkamp2024,
author = {Wolfkamp, Wouter and Meijer, Joyce and van Hoeve, Jolanda C and van Erning, Felice and de Geus-Oei, Lioe-Fee and de Hingh, Ignace and Veltman, Jeroen and Siesling, Sabine and COVID and Cancer‐NL Consortium, COVID and Cancer‐NL Consortium},
title = {Impact of the COVID ‐19 pandemic on the in‐hospital diagnostic pathway of breast and colorectal cancer in the Netherlands: A population‐based study},
journal = {Cancer Medicine},
year = {2024},
doi = {10.1002/cam4.6861}
}
EUVIMED